Comparison Between Efficacy of Topical Tranexamic Acid Vs Topical Ethyl Ascorbic Acid In Treatment Of Melasma

ConditionMelasma

Trial statusNot yet recruiting

Trial phasePhase 4

Trial typeInterventional

Biological sexAll

Age18-50

SponsorHayatabad Medical Complex

About this trial

This study is to compare the efficacy of topical tranexamic acid vs topical ethyl ascorbic acid in the treatment of melasma

Eligibility criteria

Qualifiers

Adults age 18 to 50 years Clinically diagnosed Melasma Irrespective of gender and ethnicity

Disqualifiers

pregnant and lactating women Patients with a history of skin allergies to study medications Use of systemic steroides or anti coagulants within the last month Patients on other melasma treatments for atleast 4 weeks prior

Trial design

Treatments tested in this trial

Ethyl ascorbic acid topical application
Tranxemic acid topical application

Treatment groups

128 Participants

are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Hayatabad Medical Complex

Lead sponsor

Source ClinicalTrials.gov